Jubilant Radiopharma, a business segment of Jubilant Pharmova Limited, with the second largest network of Radiopharmacies in the United States...
News
Why Choose Us / News
Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq® availability in Mobile, AL
Life Molecular Imaging (LMI) and Jubilant Radiopharma, a global company that offers radiopharmaceuticals and radiopharmacies for nuclear medicine,...
Jubilant Radiopharma Announces Investment of $50 million (USD) to Expand Positron Emission Tomography (PET) Manufacturing Network
YARDLEY, Pa.--(BUSINESS WIRE)--Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand...
Jubilant awarded Radiopharmaceutical Group Purchasing Agreement by Premier
For Immediate Release: Yardley, PA, October 25, 2019 – The Radiopharma Division of Jubilant Pharma Limited, announced today that under its...
Q BioMed Announces Commercial Partnership with Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States
Jubilant Radiopharma to Distribute Strontium-89 Chloride Injection USP Throughout the United States NEW YORK, October 3, 2019 - Q BioMed Inc....
Jubilant Pharma Announces Formation of a New Business Focused on Improving Lives Through Nuclear Medicine
Introducing Jubilant Radiopharma: An Industry Leading Pharmaceutical Company Specialized in Nuclear Medicine Focused on Developing, Manufacturing,...
Jubilant Completes Acquisition of Radiopharmacy Business of Triad Isotopes
Jubilant Pharma Limited, a material wholly owned subsidiary of Jubilant Life Sciences Ltd, through one of its wholly owned subsidiaries, has...
For Media Inquiries, please contact:
Nicole Degnan, Marketing Manager
nicole.degnan@jubl.com

